Delivering this ambition will require collaboration across the cancer ecosystem. Keep Up With Cancer (KUWC), as the ...

Boston-based Kelonia is engaged in the hot area of in vivo CAR-T therapies, presenting encouraging results with its ...

The takeover – which, if completed, will be the third acquisition for UCB this decade – involves an upfront payment of $650 ...

Eli Lilly is rumoured to be planning to spend some more of the cash raked in from its fast-growing incretin therapies for ...

Boehringer Ingelheim has announced it is expanding its global Computational Innovation footprint with a new centre dedicated to AI and machine learning (ML) in King’s Cross, London, UK – part of the ...

AstraZeneca's IL-33-targeting antibody tozorakimab has hit the target in the third of three phase 3 trials in chronic ...

Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior ...

In this week's second major AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, designed to ...

President Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of ...

Eli Lilly says it has the safety data it needs to shore up the recent speedy approval of its oral obesity therapy Foundayo, ...

The British Business Bank (BB) has agreed to make a £100 million investment in a new healthcare fund launched by London-based ...

The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety ...